Navigation Links
Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
Date:8/31/2007

SAN DIEGO, Aug. 31 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the BioCentury NewsMakers Conference on Thursday, September 6, 2007 at 2:30 p.m. ET in New York, at the Thomas Weisel Healthcare Conference on Friday, September 7, 2007 at 9:10 a.m. ET in Boston and at the Bear Stearns Healthcare Conference on Monday, September 10, 2007 at 9:00 a.m. ET in New York. Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmaceuticals, will be providing a corporate overview at BioCentury NewsMakers and Thomas Weisel. Mark G. Foletta, Senior Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, will be providing a corporate overview at Bear Stearns.

The live presentations and breakout sessions will be webcast, and recordings will be made available following the events. The webcasts and recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is locate
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ONTO, Nov. 24 /PRNewswire-FirstCall/ - Hamilton Th...nc., a leading provider of advanced laser systems ...tility clinic markets, today reported operational ...September 30, 2009. , , Q3 2009 Highlights, ...3 million in Q3 2008, - Gross profit margin w...
(Date:11/24/2009)... Arena Pharmaceuticals, ...ompany is scheduled to present at the Piper Jaffra..., 2009 at 11:30 a.m. Eastern Time (8:30 a.m. Pacif...City. Jack Lief, Arena,s President and Chief Execu...of the company, including its clinical development...
(Date:11/24/2009)...e/--HealthRoboticstodayannounced,thatithasformedan...rs.ThisrecentlyformedToronto-basedcompanywillopera...ket,install,andsupport,HealthRobotics,i.v.Roomofth...ctofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM)...eonan"asneeded,basis"toitsstrategicpartnershipswit...
(Date:11/24/2009)...acts Service (CAS), the global expert on chemical ... now the world,s leading producer of patent invent...,s patent office, the World Intellectual Property ...and Trademark Office (USPTO) for more than a decad... exceeded Japan for the first time on a monthly ba...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
... , , , , , , , ...,from Swabs in Research Samples , , ...ample extraction from a,variety of sites, and fo...(bacteria, fungi, or viruses). After the,swab pr...eased into a culture medium or onto a culture plat...
... , , , , , , , ...binant,reverse transcriptase (RT) expressed in E...se activity,DNA-dependent DNA polymerase activi...H activity. , , , , , Due...tor,Reverse Transcriptase, the individual enzyma...
... , , , , , , , ... RNase inhibitor and inhibits a wide known spectru...e performance of enzymes in an assay - even,when...ncentration) of,Protector RNase Inhibitor are ne...lly active over a wide pH range of 5.0 9.0. ,,...
Other Biology Technology:S.E.T.S. Swab Extraction Tube System 2Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 2Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 3Increase the Power and Sensitivity for Your cDNA,Synthesis with the New Transcriptor Reverse Transcriptase 4Protector RNase Inhibitor Enhance the Protection of,RNA against Degradation 2
(Date:11/26/2009)...November 2009 What are the bare essentials of lif...ce a cell that can survive on its own? Can we desc...nd how an entire organism functions as a system? T...s in a partnership between the European Molecular ...and the Centre de Regulacio Genmica (CRG) in Barce...
(Date:11/25/2009)...produced in the stomach, may be used to boost resi... disease, Yale School of Medicine researchers repo...Journal of Neuroscience . , Parkinson,s disease ... an area of the midbrain known as the substantia n.... Reduced production of dopamine in late-stage Pa...
(Date:11/25/2009)..., Head of the Cell Death Research Laboratory in th... been awarded the prestigious Johnson & Johnson Fo... cause of brain cell damage in Parkinson,s disease...sts in support of innovation and excellence in sci...red earlier this month at an event at the Hyatt Re...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 1Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 2Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 3Argonne Anti Jet Lag Diet Helps Summer Travelers Beat Jet Lag 47559 1Argonne Anti Jet Lag Diet Helps Summer Travelers Beat Jet Lag 47559 2Streamwood Hospital Opens New Childrens Center to Meet Vital Community Need 47557 1Streamwood Hospital Opens New Childrens Center to Meet Vital Community Need 47557 2
...be a hand-held device that instantly identifies an...University of Florida researcher. , That may be po...the first test quantifying the effectiveness of a ...lls. With an error rate as low as 4 percent, two U...llected from around the world by analyzing tissue ...
...ctivity of several embryonic stem cell genes is el... some of the first molecular evidence of a link be...ng, reported in the November issue of Cancer, sugg...ment of tumors or serve as valuable markers of tum...genes ultimately could lead to new targets for the...
...ated with the primary goal of facilitating medical...uman diseases. To coordinate with the journal Na...rnal Genome Research is announcing a special iss...irely devoted to studies using these data to provi...dicting pregnancy success , Successful human re...
Other Biology News:UF study first to quantify validity of DNA I.D. tool using marine snails 2UF study first to quantify validity of DNA I.D. tool using marine snails 3Study hints at role of stem cell genes in testicular, breast cancers 2Study hints at role of stem cell genes in testicular, breast cancers 3Study hints at role of stem cell genes in testicular, breast cancers 4Studies on human genome variation provide insight into disease 2Studies on human genome variation provide insight into disease 3Studies on human genome variation provide insight into disease 4
... inL10 Workstation from Caliper represents a revol...y, offering for the first time the ability to gene...ly react to changing conditions. In addition, eac... viscosity due to changes in temperature, and offe...
... Series of systems provide fast and reliable scala...s, proteomics and drug development laboratories. S...urations; Mini Workstation Series, Application Ser...cation Series systems use a revolutionary new base...
...over 20 years of experience in providing versatile...the Freedom EVO platform delivers even more flexib... future needs. Together with the new easy-to-use s...to successfully operate genomics, proteomics, and ...
...n Filter is a novel disposable spin filtration dev...f bacterial lysates in plasmid purification proced...disposable spin filtration device especially desig...in plasmid purification procedures. The neutralize...
Biology Products: